A detailed history of Global Retirement Partners, LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Global Retirement Partners, LLC holds 3 shares of DNLI stock, worth $69. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3
Previous 3 -0.0%
Holding current value
$69
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024

SELL
$20.96 - $31.05 $167 - $248
-8 Reduced 72.73%
3 $0
Q1 2024

Apr 23, 2024

BUY
$15.83 - $23.35 $126 - $186
8 Added 266.67%
11 $0
Q1 2022

Jul 14, 2022

BUY
$29.0 - $47.27 $87 - $141
3 New
3 $0
Q1 2021

Apr 14, 2021

SELL
$53.8 - $81.53 $10,760 - $16,306
-200 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$17.99 - $24.65 $3,597 - $4,930
200 New
200 $5,000

Others Institutions Holding DNLI

About Denali Therapeutics Inc.


  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $3.13B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Global Retirement Partners, LLC Portfolio

Follow Global Retirement Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Global Retirement Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Global Retirement Partners, LLC with notifications on news.